These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 18678515

  • 1. Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties.
    Frecer V, Berti F, Benedetti F, Miertus S.
    J Mol Graph Model; 2008 Oct; 27(3):376-87. PubMed ID: 18678515
    [Abstract] [Full Text] [Related]

  • 2. Combinatorial design of nonsymmetrical cyclic urea inhibitors of aspartic protease of HIV-1.
    Frecer V, Burello E, Miertus S.
    Bioorg Med Chem; 2005 Sep 15; 13(18):5492-501. PubMed ID: 16054372
    [Abstract] [Full Text] [Related]

  • 3. Development of pseudopeptide inhibitors of HIV-1 aspartic protease: analysis and tuning of the subsite specificity.
    Tossi A, Antcheva N, Romeo D, Miertus S.
    Pept Res; 1995 Sep 15; 8(6):328-34. PubMed ID: 8838416
    [Abstract] [Full Text] [Related]

  • 4. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
    Friedler A, Blumenzweig I, Baraz L, Steinitz M, Kotler M, Gilon C.
    J Mol Biol; 1999 Mar 19; 287(1):93-101. PubMed ID: 10074409
    [Abstract] [Full Text] [Related]

  • 5. Structure-based design and synthesis of substituted 2-butanols as nonpeptidic inhibitors of HIV protease: secondary amide series.
    Reich SH, Melnick M, Pino MJ, Fuhry MA, Trippe AJ, Appelt K, Davies JF, Wu BW, Musick L.
    J Med Chem; 1996 Jul 05; 39(14):2781-94. PubMed ID: 8709109
    [Abstract] [Full Text] [Related]

  • 6. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S, Mavromoustakos T, Chronakis N, Papadopoulos MG.
    Bioorg Med Chem; 2008 Dec 01; 16(23):9957-74. PubMed ID: 18996019
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approach.
    Jenwitheesuk E, Samudrala R.
    Antivir Ther; 2005 Dec 01; 10(1):157-66. PubMed ID: 15751773
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Receptor-independent 4D-QSAR analysis of a set of norstatine derived inhibitors of HIV-1 protease.
    Senese CL, Hopfinger AJ.
    J Chem Inf Comput Sci; 2003 Dec 01; 43(4):1297-307. PubMed ID: 12870923
    [Abstract] [Full Text] [Related]

  • 16. A computational study of the resistance of HIV-1 aspartic protease to the inhibitors ABT-538 and VX-478 and design of new analogues.
    Nair AC, Miertus S, Tossi A, Romeo D.
    Biochem Biophys Res Commun; 1998 Jan 26; 242(3):545-51. PubMed ID: 9464253
    [Abstract] [Full Text] [Related]

  • 17. Efficiency of a second-generation HIV-1 protease inhibitor studied by molecular dynamics and absolute binding free energy calculations.
    Lepsík M, Kríz Z, Havlas Z.
    Proteins; 2004 Nov 01; 57(2):279-93. PubMed ID: 15340915
    [Abstract] [Full Text] [Related]

  • 18. Optimization and computational evaluation of a series of potential active site inhibitors of the V82F/I84V drug-resistant mutant of HIV-1 protease: an application of the relaxed complex method of structure-based drug design.
    Perryman AL, Lin JH, Andrew McCammon J.
    Chem Biol Drug Des; 2006 May 01; 67(5):336-45. PubMed ID: 16784458
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative studies on inhibitors of HIV protease: a target for drug design.
    Jayaraman S, Shah K.
    In Silico Biol; 2008 May 01; 8(5-6):427-47. PubMed ID: 19374129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.